A5009940202- Sepsis Diagnosis and Treatment
- Intensive Care Unit Cognitive Disorders
- Cancer Treatment and Pharmacology
- Chronic Lymphocytic Leukemia Research
- Colorectal Cancer Treatments and Studies
- Trauma, Hemostasis, Coagulopathy, Resuscitation
- Nosocomial Infections in ICU
- Disaster Response and Management
- Hemodynamic Monitoring and Therapy
- Hepatocellular Carcinoma Treatment and Prognosis
- Infectious Encephalopathies and Encephalitis
- Respiratory Support and Mechanisms
- Cardiac Imaging and Diagnostics
- Calcium signaling and nucleotide metabolism
- Cardiovascular Function and Risk Factors
- Health and Medical Education
- Travel-related health issues
- Public Health and Environmental Issues
- HER2/EGFR in Cancer Research
- Cardiovascular Issues in Pregnancy
- Blood transfusion and management
- Trauma and Emergency Care Studies
- Family and Patient Care in Intensive Care Units
- Muscle and Compartmental Disorders
- Electrolyte and hormonal disorders
Central America Health Sciences University
2017-2024
Care International
2023
New York University
2017
Centro Científico Tecnológico - Mendoza
2010
University of Mendoza
2008
Objective: To provide an update to “Surviving Sepsis Campaign Guidelines for Management of and Septic Shock: 2012.” Design: A consensus committee 55 international experts representing 25 organizations was convened. Nominal groups were assembled at key meetings (for those members attending the conference). formal conflict-of-interest (COI) policy developed onset process enforced throughout. stand-alone meeting held all panel in December 2015. Teleconferences electronic-based discussion among...
Extracorporeal blood purification with CytoSorb has been increasingly used as an adjunctive therapy in several hyperinflammatory critical care conditions, well to remove elevated levels of myoglobin or bilirubin patients rhabdomyolysis liver failure. Despite the increasing worldwide use hemoadsorption, data from large international multicenter studies are still lacking.
Objectives: Irinotecan or oxaliplatin combined with 5-fluorouracil (5-FU) ± folinic acid (FA) has changed the treatment standards for metastatic colorectal cancer (CRC). The and irinotecan combination reported consistent activity. purpose of this phase II study was to assess efficacy safety simultaneous administration a triple chemotherapy oxaliplatin, irinotecan, 5-FU bolus, FA. Materials Methods: Eligible patients had CRC no prior irinotecan-based chemotherapy. Treatment consisted 85 mg/m2...
<sec> <title>BACKGROUND</title> Extracorporeal blood purification with CytoSorb® has been widely used as an adjunctive therapy in several hyperinflammatory critical care conditions well to remove elevated levels of myoglobin or bilirubin patients rhabdomyolysis liver failure. </sec> <title>OBJECTIVE</title> The COSMOS (CytOSorb TreatMent Of Critically Ill PatientS) Registry will provide a data repository and reporting infrastructure for the surveillance use real-world settings serve...